Company Overview and News

2
UPDATE 1-Japan Q4 aluminium premiums set 22 percent lower than Q3 - sources

2018-10-01 reuters
TOKYO (Reuters) - Premiums for Japanese aluminum shipments for the October to December quarter were set at $103 per tonne, down 22 percent from the previous quarter, as Asian spot premiums fell amid ample supply, four sources directly involved in the pricing talks said.
RTPPF RIO RIO RIO RUALF MARUF RTNTF SOUHY SHTLF

 
UPDATE 1-China exporting alumina again as soaring prices upend market

2018-08-29 reuters
BEIJING/MELBOURNE (Reuters) - China is shipping unusually high volumes of alumina for a second time this year to an international market desperate for the ingredient used to make aluminum, traders and analysts said, even as domestic prices rise and put pressure on smelters.
AWCMY AAI AWCMF SOUHY AA CHHQY SHTLF CHHQF

 
China exporting alumina again as soaring prices upend market

2018-08-28 reuters
BEIJING/MELBOURNE, Aug 28 (Reuters) - China is shipping unusually high volumes of alumina for a second time this year to an international market desperate for the ingredient used to make aluminium, traders and analysts said, even as domestic prices rise and put pressure on smelters.
AWCMY AAI AWCMF SOUHY AA CHHQY SHTLF CHHQF

 
South32 Ltd. ADR 2018 Q4 - Results - Earnings Call Slides

2018-08-23 seekingalpha
The following slide deck was published by South32 Ltd. ADR in conjunction with their 2018 Q4 earnings call.
SOUHY SHTLF

 
Africa Down Under Conference Perth to highlight mining and energy investments

2018-08-22 proactiveinvestors.com.au
Africa Down Under Conference Perth kicks off next Wednesday as mines ministers, government delegates and leaders of key Australian companies operating in Africa converge amid the mining sector’s resurgence.
CLA BSSMF IGO S32 AZM BSRUF CDNL RSG BSE BKT LOM RMGGF ILKAY BSM SOUHY ILKAF IIDDY ILU CDV BSE ORN SRI RMGGY AZUMF SHTLF

 
AusQuest identifies potential porphyry copper system at Chololo project

2018-08-07 proactiveinvestors.com.au
AusQuest Ltd (ASX:AQD) has completed seven drill holes of the ongoing diamond drilling program at its Chololo Copper Project in southern Peru.
SOUHY S32 SHTLF AQD

 
Miners Set to Spend $11 Billion in Search of the Next Jackpot

2018-08-06 theedgemarkets
(Aug 7): Miners and investors are poring over satellite images, tracking drilling rigs and quizzing company executives for clues on whether the sector’s heavyweights are close to a new jackpot discovery.
ELKMF NCMGF NCM GFI.WI AYR NEM SOUHY AAL FSUGY NCMGY FSUMF SRI GOR AAUKF GFI FMG AZY GFIOF NGLOY SHTLF

 
Miners Set to Spend $11 Billion in Search of the Next Jackpot - Bloomberg

2018-08-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ELKMF NCMGF NCM GFI.WI AYR NEM SOUHY AAL FSUGY NCMGY FSUMF SRI GOR AAUKF GFI FMG AZY GFIOF NGLOY SHTLF

 
Arizona Mining Obtains Final Order for Plan of Arrangement

2018-08-03 globenewswire
VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX: AZ) (“Arizona Mining” or the “Company”) announces that it has obtained a final order from the Supreme Court of British Columbia (the “Final Order”) approving the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) whereby South32 Limited (“South32”), will acquire all of the issued and outstanding common shares of the Company (“Common Shares”) not already owned by South32 or its affiliates for C$6.
AZ SOUHY SHTLF

 
Arizona Mining Shareholders Approve Plan of Arrangement

2018-08-02 globenewswire
VANCOUVER, British Columbia, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX: AZ) (“Arizona Mining” or the “Company”) announces the voting results from today’s special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares of the Company (the “Common Shares”). At the Meeting, the Shareholders were asked to consider and, if deemed advisable, pass a special resolution (the “Arrangement Resolution”) approving a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) whereby South32 Limited (“South32”), will acquire all of the issued and outstanding Common Shares not already owned by South32 or its affiliates for C$6.
AZ SOUHY SHTLF

1
The Complete Industrial Minefinder Junior Index (IMJI)

2018-08-01 seekingalpha
The IMJI™ is an index of 50 junior miners involved in the exploration and development of industrial metals (everything but gold).
LTUM SOUHY SHTLF

 
Arizona Mining Receives Interim Order for Plan of Arrangement - Shareholder Meeting Set for August 2, 2018

2018-07-03 globenewswire
VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) announced that it obtained an interim order of the Supreme Court of British Columbia on June 29, 2018 providing for, among other things, the holding of a special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of the Company to consider the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) pursuant to which South32 Limited (“South32”) will acquire all of the Company’s outstanding Common Shares not already owned by South32 and its affiliates for C$6.
AZ SOUHY SHTLF

1
Arizona Mining Will Be Acquired By South32: A Good Deal?

2018-06-27 seekingalpha
That's 12.4 times higher than the C$0.50 Arizona Mining was trading at when it was originally discussed here.
SOUHY LNSTY SHTLF

11
Top Silver Stocks For 2018: Midyear Update

2018-06-26 seekingalpha
My top picks for 2018 were Coeur Mining, New Pacific Metals, SilverCrest Metals, Arizona Mining and Silvercorp.
CDE SVCMF NUPMF NUXFF PAAS SOUHY NUX CDEUW SIL

 
Silver Bull Announces Private Placement of US$3 Million

2018-06-26 globenewswire
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
SVBL SVB SOUHY S32 S32 SHTLF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 84473L105